Jan Bruder's Biography

• Home
• |
• Register
• |
• Submissions
  • Submission Guidelines
  • Submissions
• |
• Agenda
  • Keynote Speakers
  • Agenda Day 1
  • Agenda Day 2
• |
• Exhibition
• |
• Venue
• |
• Media
  • Media Partners
• |
• Reception
• |

iPS-based Automated Drug Screening: From Human iPS to Midbrain Dopaminergic Neurons

Wednesday, 14 May 2014 at 17:30

Add to Calendar ▼2014-05-14 17:30:002014-05-14 18:30:00Europe/LondoniPS-based Automated Drug Screening: From Human iPS to Midbrain Dopaminergic NeuronsAdvances in Automation and Robotics in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

We provide an overview over our methods allowing us to differentiate human neural precursor cells generated from iPS cultures into midbrain dopaminergic neurons in a fully automated fashion. The resulting cell cultures can serve as a scalable disease model for familial Parkinson's disease based on a LRRK2 2019S mutation and allows for screening compounds in a human neural model system.